Vasculitis clinical trials at UCSF

1 research study open to eligible people

Vasculitis is inflammation that harms blood vessels. UCSF is evaluating a medication that lowers immune activity for bulging arteries near the brainstem. Doctors collect scans and monitor for stroke or bleeding.

Showing trials for

  • Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

    open to eligible people ages 18 years and up

    Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive treatment due to the futility of existing surgical methods. Consequently, there is demand for development of medical therapy for DVB aneurysms

    San Francisco, California

Our lead scientists for Vasculitis research studies include .

Last updated: